Clinical Trials Logo
  1. Home
  2. Stomach Ulcer
  3. NCT01167101

Is Rebamipide Effective on the Healing of Iatrogenic Gastric Ulcer After Endoscopic Mucosal Resection?

Stomach Ulcer Clinical Trial

Official title:
Is Rebamipide Effective on the Healing of Iatrogenic Gastric Ulcer After Endoscopic Mucosal Resection? : Multicenter, Randomized, and Prospective Study

Clinical Trial Summary

Treatment strategy of post endoscopic submucosal dissection (ESD) ulcer is not yet conclusive. Rebamipide is a mucosal protective agent widely used in East Asia and has good effect on quality of ulcer healing (QOUH). The investigators will conduct this randomized controlled study to assess the effect of a combination therapy of rebamipide and proton pump inhibitor (PPI) on post ESD ulcer healing.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01167101
Study type Interventional
Source Kangdong Sacred Heart Hospital
Contact
Status Completed
Phase N/A
Start date May 2009
Completion date December 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT02299687 - Influence of CYP2C19 Polymorphism on PK/PD of Omeprazole Phase 1
Completed NCT00284908 - Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers Phase 1
Completed NCT00239551 - Effect of Prevacid on Prostaglandin Levels in Patient With Stress Ulcer Phase 4
Completed NCT02710994 - Pharmacodynamics and Safety of CDFR0209 Phase 1
Terminated NCT00762359 - A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcers Phase 3
Completed NCT01376414 - H. Pylori Testing for Patients With Non-specific Upper Abdominal Pain in the Emergency Department N/A
Completed NCT00543868 - MK0782 + Low-Dose Aspirin 7-Day Erosion Endoscopy Study (0782-001) Phase 2
Completed NCT05208268 - A Study of Pariet to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin in Korean Participants With a History of Gastric and Duodenal Ulcer
Completed NCT02032030 - Systematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes Surveys
Completed NCT00272467 - Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication Therapy Phase 4
Completed NCT03060733 - Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Completed NCT03060746 - Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Completed NCT00125736 - A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium Phase 4
Completed NCT00233389 - Post-marketing Clinical Study of Rebamipide in Patients With Gastric Ulcer Phase 4
Terminated NCT00839488 - Comparison of Intravenous Pantoprazole and Famotidine for Stress Ulcer Prophylaxis Phase 4
Completed NCT00787254 - Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory Drugs Phase 3
Completed NCT00190255 - Pharmacogenetics of Gastrointestinal Bleeding Phase 4